Brought to you by 
Evalve closes $35mm Series C round; $15mm from Guidant
03 Jun 2004
Executive Summary
Evalve Inc. (devices for the endovascular repair of cardiac valves) raised $35mm in a Series C financing led by Guidant Corp., which invested $15mm and could add another $15 million if certain milestones are achieved. Returning shareholders New Enterprise Associates, Delphi Ventures, St. Paul Venture Capital, Three Arch Partners, Cutlass Capital, and ABS Ventures also participated.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Evalve closes $35mm Series C round; $15mm from Guidant
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice